{"id":"https://openalex.org/W13517399","doi":null,"title":"Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.","display_name":"Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.","alternate_titles":[],"publication_year":1995,"publication_date":"1995-09-01","ids":{"openalex":"https://openalex.org/W13517399","mag":"13517399","pmid":"https://pubmed.ncbi.nlm.nih.gov/9166480"},"language":"en","primary_location":{"id":"pmid:9166480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9166480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The cancer journal from Scientific American","raw_type":"Clinical Trial, Phase II"},"parent_works":[],"lineage":["https://openalex.org/W13517399"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010839753","display_name":"Nacer Azli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N Azli","raw_affiliation_strings":["Institut Gustave Roussy, Savigny Le Temple, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Savigny Le Temple, France","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047771337","display_name":"Abderrahim Fandi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Fandi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074709364","display_name":"M. Bachouchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bachouchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079530585","display_name":"M. Rahal","orcid":"https://orcid.org/0000-0002-3790-1270","observed_orcids":["https://orcid.org/0000-0002-3790-1270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Rahal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053895349","display_name":"PILAR LIANES","orcid":"https://orcid.org/0000-0002-4976-9246","observed_orcids":["https://orcid.org/0000-0002-4976-9246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Lianes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110276057","display_name":"Pierre Wibault","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Wibault","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108876703","display_name":"Hammouda Boussen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Boussen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110214387","display_name":"F Eschw\u00e8ge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Eschwege","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109930287","display_name":"Jean\u2010Pierre Armand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Armand","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055631929","display_name":"Esteban Cvitkovic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Cvitkovic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9062,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.8349768,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"1","issue":"3","first_page":"222","last_page":"229"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11669","display_name":"Head and Neck Surgical Oncology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.8759999871253967},{"id":"https://openalex.org/keywords/undifferentiated-carcinoma","display_name":"undifferentiated carcinoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":0.7379999756813049},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9129999876022339},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.8519999980926514},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.781000018119812},{"id":"https://openalex.org/keywords/recurrent-nasopharyngeal-carcinoma","display_name":"recurrent nasopharyngeal carcinoma","score":0.7540000081062317},{"id":"https://openalex.org/keywords/metastatic-nasopharyngeal-carcinoma","display_name":"metastatic nasopharyngeal carcinoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/locoregionally-advanced-disease","display_name":"locoregionally advanced disease","score":0.8410000205039978},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6240000128746033},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5630000233650208},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.9375565052032471},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9248270988464355},{"id":"https://openalex.org/C2778997737","wikidata":"https://www.wikidata.org/wiki/Q1693598","display_name":"Nasopharyngeal carcinoma","level":3,"score":0.7464966773986816},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.7145103216171265},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6870955228805542},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6136444807052612},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5668190717697144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5507107377052307},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5054202079772949},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4886472821235657},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4135858714580536},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40641605854034424},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3610580265522003},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.11572974920272827}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009303","descriptor_name":"Nasopharyngeal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009303","descriptor_name":"Nasopharyngeal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009303","descriptor_name":"Nasopharyngeal Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9166480","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9166480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The cancer journal from Scientific American","raw_type":"Clinical Trial, Phase II"},{"id":"mag:13517399","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9166480","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2069824794","https://openalex.org/W2166813563","https://openalex.org/W2225793510","https://openalex.org/W2073469599","https://openalex.org/W1582933319","https://openalex.org/W2409573417","https://openalex.org/W182988086","https://openalex.org/W2143822310","https://openalex.org/W1998259127","https://openalex.org/W1994558035"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"article":[2],"presents":[3],"an":[4],"assessment":[5],"of":[6,9,22,25,53,81,137,148,220,254,270,305,339],"the":[7,20,26,138,232,252,256,275,306,340],"combination":[8,308],"bleomycin,":[10],"epirubicin,":[11],"and":[12,36,57,93,178,226,244,279,288,315],"cisplatin":[13,83],"as":[14],"induction":[15],"chemotherapy":[16,237,342],"before":[17],"radiotherapy":[18,155],"in":[19,29,37,51,126,164,206,313,321,327],"treatment":[21],"undifferentiated":[23],"carcinoma":[24],"nasopharyngeal":[27],"type":[28],"patients":[30,40,71,125,162,191,208,214,328],"with":[31,41,72,78,143,211,217,240,318,329],"recurrent/metastatic":[32],"disease":[33,44,221,332,351],"(group":[34,49],"A),":[35],"previously":[38,193,209],"untreated":[39],"locoregionally":[42,349],"advanced":[43,331,350],"(UICC-AJCC":[45],"87,":[46],"N2-3,":[47],"M0)":[48],"B)":[50],"terms":[52],"toxicity,":[54],"antitumoral":[55],"activity,":[56],"therapeutic":[58],"efficacy.":[59],"PATIENTS":[60],"AND":[61],"METHODS:":[62],"From":[63],"January":[64],"1987":[65],"to":[66,123,202,236,344],"September":[67],"1990,":[68],"111":[69],"consecutive":[70],"histologically":[73],"proven":[74],"UCNT":[75],"were":[76,121,141,168,197],"treated":[77,210],"six":[79],"cycles":[80,118,136],"intravenous":[82],"(100":[84],"mg/m2":[85,90],"day":[86,91,98],"1)":[87],"epirubicin":[88,149],"(80":[89],"1),":[92,99],"bleomycin":[94,120],"(15":[95],"mg":[96],"bolus":[97],"followed":[100,152],"by":[101,153],"16":[102],"mg/m2/day":[103],"continuous":[104],"infusion":[105],"for":[106,113,170,183,283],"5":[107,203],"days,":[108],"repeated":[109],"every":[110],"21":[111],"days":[112],"three":[114,135],"cycles.":[115],"Three":[116,249],"further":[117],"without":[119],"given":[122,194],"44":[124,161],"group":[127,130,165,230,285],"A.":[128],"In":[129,189,229],"B":[131,231],"(67":[132],"patients),":[133],"only":[134],"same":[139],"protocol":[140],"given,":[142],"a":[144,184,266],"slightly":[145],"lower":[146],"dose":[147],"(70":[150,156],"mg/m2),":[151],"conventional":[154],"Gy/7":[157],"weeks).":[158],"RESULTS:":[159],"Of":[160],"entered":[163],"A,":[166],"38":[167],"evaluable":[169],"response.":[171],"We":[172],"observed":[173],"9":[174],"(20%)":[175],"complete":[176,199,204,242,258],"responses":[177,205,247],"11":[179],"(25%)":[180],"partial":[181,246],"responses,":[182,200],"45%":[185],"overall":[186,233,257,277],"response":[187,234,259],"rate.":[188],"12":[190],"not":[192,296],"chemotherapy,":[195],"there":[196],"4":[198],"compared":[201],"32":[207],"chemotherapy.":[212],"Four":[213],"are":[215,286,310],"alive":[216],"no":[218],"evidence":[219],"after":[222,251],"53+,":[223],"60+,":[224],"61+,":[225],"72+":[227],"months.":[228,301],"rate":[235,260],"was":[238,261],"98%":[239],"42":[241],"(62%)":[243],"24":[245],"(36%).":[248],"months":[250,272],"end":[253],"radiotherapy,":[255],"94%":[262],"(63":[263],"patients).":[264],"After":[265],"median":[267,292],"follow-up":[268],"time":[269],"77":[271],"(range,":[273],"53-94),":[274],"4-year":[276],"survival":[278,281,294],"disease-free":[280,293],"rates":[282],"this":[284,322],"66%":[287],"60%,":[289],"respectively.":[290],"The":[291,303,325],"has":[295],"been":[297],"reached":[298],"at":[299],"90":[300],"CONCLUSION:":[302],"results":[304,326],"BEC":[307],"trial":[309],"very":[311],"encouraging":[312],"metastatic":[314],"recurrrent":[316],"UCNT,":[317],"durable":[319],"remissions":[320],"poor-prognosis":[323],"population.":[324],"locally":[330],"have":[333],"motivated":[334],"prospective":[335],"phase":[336],"III":[337],"testing":[338],"neoadjuvant":[341],"approach":[343],"evaluate":[345],"its":[346],"impact":[347],"on":[348],"(>":[352],"or":[353],"=N2MO":[354],"UICC-AJCC":[355],"87).":[356]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W13517399","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
